News Quantified

NKTR – nektar therapeutics (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript [Yahoo! Finance]

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]

Nektar Therapeutics Reports First Quarter 2024 Financial Results [Yahoo! Finance]

Nektar Therapeutics Reports First Quarter 2024 Financial Results

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets [Yahoo! Finance]

10.0%

BEAT

-1.9%

MISS

-8.8%

MISS

-7.4%

BEAT

Form 144 NEKTAR THERAPEUTICS Filed by: Zalevsky Jonathan

Form 144 NEKTAR THERAPEUTICS Filed by: Wilson Mark Andrew

Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W

Form 4 NEKTAR THERAPEUTICS For: May 10 Filed by: Deep Track Biotechnology Master Fund, Ltd.

Form 10-Q NEKTAR THERAPEUTICS For: Mar 31

Top News Gainers

1/10 Form 8-K NEKTAR THERAPEUTICS For: Jan 09 23.0%

9/9 Form 4 NEKTAR THERAPEUTICS For: Sep 05 Filed by: Doberstein Stephen K 11.5%

12/6 Form 8-K NEKTAR THERAPEUTICS For: Dec 05 10.2%

8/9 Nektar Therapeutics (NASDAQ: NKTR) had its price target lowered by analysts at BMO Capital Markets to $41.00. They now have an "outperform" rating on the stock. 10.1%

6/2 Nektar Therapeutics (NASDAQ: NKTR) was given a new $82.00 price target on by analysts at Cowen Inc. They now have a "buy" rating on the stock. 9.9%

2/28 Nektar Therapeutics (NASDAQ: NKTR) had its "outperform" rating re-affirmed by analysts at William Blair. 9.5%

5/9 Nektar Therapeutics (NKTR) Q1 2019 Earnings Call Transcript [The Motley Fool] 9.1%

11/19 Form 8-K NEKTAR THERAPEUTICS For: Nov 13 7.8%

11/7 Nektar Therapeutics (NASDAQ: NKTR) had its price target lowered by analysts at Piper Jaffray Companies from $50.00 to $35.00. They now have an "overweight" rating on the stock. 7.5%

3/13 Nektar Therapeutics (NASDAQ: NKTR) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.1%

Top News Decliners

8/8 Q2/2019 6/30/2019 EPS -0.630 ZacksConsensus -0.800 ActVsEst 0.170 - Beat -29.3%

1/14 Nektar Therapeutics (NKTR) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow [Seeking Alpha] -16.0%

3/13 Form 4 NEKTAR THERAPEUTICS For: Mar 11 Filed by: CHESS ROBERT -13.4%

8/10 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm -11.2%

11/15 Form 4 NEKTAR THERAPEUTICS For: Nov 13 Filed by: Labrucherie Gil M -8.4%

5/15 Nektar Therapeutics Announces Five Accepted Abstracts at 2019 American Society of Clinical Oncology's (ASCO) Annual Meeting -7.8%

10/8 Nektar Therapeutics (NASDAQ: NKTR) was downgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "sell" rating. They now have a $16.00 price target on the stock, down previously from $54.00. -7.5%

8/4 More Potential FDA Opioid Delays In Nektar's Wake [Seeking Alpha] -7.4%

9/26 Clinical Data Presented from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Triple-Negative Breast Cancer Patients at the 2019 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference -6.8%

10/1 Form 4 NEKTAR THERAPEUTICS For: Sep 27 Filed by: CHESS ROBERT -6.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day